Therapeutic Use Exemption Committee (TUE committee)
There were almost no amendments to the regulations relating to exemptions in 2017 by comparison with 2016.
In the end, exemptions were granted in 125 cases. That was a striking rise by comparison with previous years. Applications were turned down in six cases.
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | |
|---|---|---|---|---|---|---|
| Granted | 82 | 89 | 88 | 99 | 97 | 125 |
| Rejected | 1 (1,2%) | 4 (4,3%) | 6 (6,4%) | 8 (7,5%) | 5 (4,9%) | 6 (4,6%) |
As in most recent years, the majority of exemptions related to the use of methylphenidate (62). In percentage terms, that is 49.6%, a slight fall by comparison with 2016.
Other medication for which exemptions were often granted were insulin (11.2%) and prednisone/prednisolone (10.4%).
The applications came from a total of 32 different sports associations.
With 16 applications granted, the KNWU was the organisation with most exemptions (12.8%), as was the case in most other years, followed by the KNZB (10.4%), and the Athletics Union (8.8%).
An appeal was lodged with the Appeals Committee for Therapeutic Use Exemptions for the first time in 2017. The appeal was successful.
The TEU committee welcomed a new member, Dr. Ivo van Outheusden, in 2017. He replaced Dr. Hans Keizer.